Results 81 to 90 of about 23,067 (190)

Safety of 8‐Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi‐Center, Double‐Blinded, Placebo‐Controlled Study

Phytotherapy Research, Volume 40, Issue 8, Page 5005-5015, August 2026.
ABSTRACT Ashwagandha ( Withania somnifera ) has been recognized for enhancing physical strength, mental well‐being, and overall vitality. Despite its long‐standing use across generations, some clinical reports have noted occasional adverse events. This study compared the safety and tolerability of Ashwagandha Root Extract (ARE) in healthy adults.
Ketan Pakhale, Jaising Salve, John Ademola, Jose Parraca, Deepak Langade   +4 more
wiley   +1 more source

Theatres of Indirectness: Passive Aggression and Failure

Critical Quarterly, EarlyView.
Sara Crangle, Sam Ladkin
wiley   +1 more source

The Effect of Benzodiazepines on Catatonia: A Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica, Volume 154, Issue 2, Page 99-115, August 2026.
ABSTRACT Introduction Catatonia is a complex psychomotor syndrome associated with various psychiatric and somatic underlying disorders. Current treatment protocols include benzodiazepines and electroconvulsive therapy (ECT). Despite their widespread use, systematic evidence regarding efficacy and optimal benzodiazepine dosage remains limited.
L. Bot, B. Schotsman, E. Oostra, A. W. Hoogendoorn, B. W. C. Storosum, C. H. M. Planting, H. M. Heller, J. J. B. van der Vlugt, J. G. van Mill, L. J. C. A. Smarius, M. S. Oudijn, M. S. van Noorden, S. M. M. Lange, Y. D. van der Werf, E. van Exel   +14 more
wiley   +1 more source

Are we overdiagnosing bipolar disorder?

Indian Journal of Psychological Medicine, 2017
Bipolar disorder (BD) is an established diagnostic entity used by clinicians for over a century. It is distinguished by the distinct manic and depressive episodes with interepisode euthymia.
M S Reddy, Starlin M Vijay, Swetha Reddy
doaj   +1 more source

Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older‐Age Bipolar Disorder ISBD Task Forces

Bipolar Disorders, Volume 28, Issue 5, August 2026.
ABSTRACT Background Cognitive impairment is common in bipolar disorder (BD), but the underlying pathophysiology remains unclear. This systematic review aimed to (1) summarize all literature describing relationships of biofluid biomarkers and cognition in BD and (2) identify which biofluid biomarkers correlate most consistently with cognition in BD ...
Alexandra J. M. Beunders, Sigfried N. T. M. Schouws, Andrew T. Olagunju, Vicent Balanzá‐Martínez, Nicole C. M. Korten, Ralph W. Kupka, Katherine E. Burdick, Andre F. Carvalho, Ariel G. Gildengers, Lars V. Kessing, Roger S. McIntyre, Paula V. Nunes, Ayal Schaffer, Ivan J. Torres, Shang‐Ying Tsai, Tamsyn E. Van Rheenen, Eduard Vieta, Lakshmi N. Yatham, Allan H. Young, Lisa T. Eyler, Kamilla W. Miskowiak, Annemiek Dols   +21 more
wiley   +1 more source

Speech and Language Markers of Bipolar Disorder: Challenges and Opportunities

Bipolar Disorders, Volume 28, Issue 5, August 2026.
ABSTRACT Background Clinicians aspire to predict the emergence of Bipolar Disorder (BD) in a timely manner. To accomplish this, markers reflecting mental states that can be gathered non‐invasively and at large scale are needed. Here, we systematically evaluate evidence relating speech‐based markers to mood states in BD.
Farida Zaher, Jessica Ahrens, Delphine Raucher‐Chéné, Alban Voppel, Lena Palaniyappan   +4 more
wiley   +1 more source

Clinical applications of transcranial magnetic stimulation in bipolar disorder

Brain and Behavior, 2019
Background Many patients with bipolar disorder (BD) fail to experience benefit following traditional pharmacotherapy, necessitating alternative treatment options that will enable such patients to achieve remission. Transcranial magnetic stimulation (TMS)
Alexandra K. Gold, Ana Claudia Ornelas, Patricia Cirillo, Marco Antonio Caldieraro, Antonio Egidio Nardi, Andrew A. Nierenberg, Gustavo Kinrys   +6 more
doaj   +1 more source

A retrospective study of late-onset bipolar disorder: A comparison with early and intermediate onset

Journal of Geriatric Mental Health, 2017
Aim: To evaluate the sociodemographic, clinical, and treatment characteristics profile of late-onset (LO) bipolar affective disorder (BPAD) (onset ≥50 years) and compare the patients with LO BPAD with early age of onset (10–25 years) and intermediate age
Sandeep Grover, Swapnajeet Sahoo, Subho Chakrabarti, Ajit Avasthi   +3 more
doaj   +1 more source

Lithium: Potential Therapeutics Against Acute Brain Injuries and Chronic Neurodegenerative Diseases

Journal of Pharmacological Sciences, 2005
In addition to the well-documented mood-stabilizing effects of lithium in manic-depressive illness patients, recent in vitro and in vivo studies in rodents and humans have increasingly implicated that lithium can be used in the treatment of acute brain ...
Akihiko Wada, Hiroki Yokoo, Toshihiko Yanagita, Hideyuki Kobayashi   +3 more
doaj   +1 more source

Politics in poetry: epic poetry as a critique of Dutch culture

Literator, 2010
This article describes a Dutch volume of epic poetry, using a disciplinary strategy (concepts and devices from narrative studies) and a cultural analytical and rhetorical approach.
O.M. Heynders
doaj   +1 more source